Amendments to the Principal Agreement. 2.1 The Parties hereby agree to amend the Principal Agreement, and any amendments to the Principal Agreement, by replacing Clause 3.1 of the Principal Agreement in its entirety with the following: This Agreement shall come into force on the Effective Date and shall continue for a period of eighteen months (the “Term”) unless terminated earlier in accordance with the terms of this Agreement. Notwithstanding the foregoing, this Agreement may be extended by mutual written agreement of the Parties. 2.2 Save as expressly provided or varied herein, all other terms and conditions of the Principal Agreement, and all rights and liabilities accruing before this Amendment Agreement No. 2 comes into effect shall remain unaffected. 2.3 This Amendment Agreement No. 2 shall be effective as of 10th October 2017. 2.4 This Amendment Agreement No. 2 shall be read and take effect as one with the Principal Agreement.
Appears in 4 contracts
Samples: Licensing and Research Collaboration Agreement, Licensing and Research Collaboration Agreement (ASLAN Pharmaceuticals LTD), Licensing and Research Collaboration Agreement (ASLAN Pharmaceuticals LTD)
